DHL Bids to Boost Healthcare Logistics with Singapore Hub
DHL Supply Chain has opened a new Pharma Hub in Singapore, adding to its expanding Life Sciences and Healthcare (LSHC) infrastructure across Asia Pacific.
The 8,200 square metre site is part of DHL Group’s €500m (US$569m) regional investment and marks a targeted move to improve healthcare logistics and meet growing demands in the sector.
Located at 8 Jurong Pier, the hub offers temperature-controlled zones and advanced cold chain systems. These facilities help preserve the integrity of medical products through every stage of transport and storage.
The launch falls under DHL’s global Strategy 2030 and highlights the group’s commitment to delivering improved logistics for life-saving treatments and products.
Building for rising demand in Asia Pacific
DHL’s new Pharma Hub sits near Tuas Bio-Medical Park, with direct links to Changi Airport and Tuas Mega Port. This positions the site for efficient global distribution and provides a logistics backbone for pharmaceutical customers across the region.
The temperature-controlled areas include ambient zones (15°C to 25°C) and cold rooms (2°C to 8°C), ensuring safe conditions for sensitive goods.
The site is compliant with Good Manufacturing Practice (GMP) standards and equipped with airtight loading docks and anterooms to maintain uninterrupted cold chain operations.
Eunis Hew, Managing Director for DHL Supply Chain Singapore, explains the move: “With the new Pharma Hub in Jurong, we have more than 36,000 square metres of warehouse space in Singapore dedicated to LSHC operations.
"Our current operations include being the regional distribution centres for multiple medical device multi-nationals, clinical trials support and other value-added services.”
The new hub forms part of a broader expansion aimed at building infrastructure that matches the projected growth in regional healthcare.
By 2030, Asia Pacific’s medical market is expected to reach US$138bn (€127bn). This is driven by an ageing population, personalised treatments and increasing demand for accessible care.
Javier Bilbao, CEO of DHL Supply Chain Asia Pacific, sees the investment as a key enabler: “Our investment goes beyond building warehouses or expanding networks.
"It is about building a foundation across all our business units that enables faster, more reliable delivery of life-saving medicines and healthcare products.”
Connecting a network of specialised sites
The Singapore hub joins a growing network of DHL Supply Chain’s LSHC facilities across the region. In Australia, €28m (US$31m) has been invested into automation, robotics and added floor space at sites in New South Wales.
A €26m (US$29.5m) automated facility in Auckland, New Zealand includes robotic storage and Goods-to-Person (GTP) technology. South Korea and India are next in line for new sites, further widening DHL’s regional coverage.
These facilities comply with Good Distribution Practice (GDP) and GMP standards, enabling DHL to handle pharmaceuticals and medical devices that require specific conditions. Services range from cold storage and temperature-controlled transport to express deliveries with tailored handling for fragile or time-sensitive items. This logistics support enables healthcare providers and manufacturers to focus on innovation and patient outcomes.
Globally, DHL is reinforcing this infrastructure with a €2bn (US$2.27bn) investment by 2030 to develop integrated healthcare logistics. Part of this includes the acquisition of CRYOPDP, a courier service specialised in temperature-controlled transport and white-glove services for the LSHC sector.
Expertise and innovation across the supply chain
Beyond infrastructure, DHL places emphasis on trained staff. More than 2,600 LSHC logistics experts and 40+ full-time pharmacists work across its Asia Pacific operations.
These personnel are essential for managing storage, handling and transport under strict regulatory conditions. Skilled teams help ensure products stay within required temperature ranges, navigate international regulations and maintain compliance at every stage.
Technology also plays a central role. DHL integrates robotics, automation and AI into daily operations to improve accuracy and efficiency.
Predictive analytics reduce risks and improve decision-making, while Control Tower systems offer real-time supply chain visibility. Its Service Logistics network further supports the medical technology sector by managing spare parts, inventory and urgent repairs.
According to Javier, the combined effect of infrastructure, technology and talent creates a system that is built for the future of healthcare logistics: “Modern healthcare depends on more than just a physician’s expertise.
"It requires scale, connectivity and constant collaboration between manufacturers, researchers and medical experts worldwide. Healthcare can only work if its logistics do too.”
With this latest addition, DHL Supply Chain will manage more than 80 LSHC facilities, covering in excess of 700,000 square metres across 13 countries in Asia Pacific.
As healthcare needs continue to grow, this network is positioned to meet demand with speed, precision and resilience.
Explore the latest edition of Supply Chain Digital Magazine and be part of the conversation at our global conference series, Procurement & Supply Chain LIVE.
Discover all our upcoming events and secure your tickets today.
Supply Chain Digital is a BizClik brand.